Earnings

Quantum-Si (QSI) to Announce Earnings on February 26

Published February 19, 2025

Quantum-Si (NASDAQ:QSI) is set to release its quarterly earnings report after the market closes on Wednesday, February 26th. Analysts predict that the company will report a loss of ($0.19) per share, along with revenue estimated at $1.29 million for the quarter. Those who wish to participate in the earnings conference call can access it using the available link.

Recent Performance of Quantum-Si Stock

On Wednesday, Quantum-Si shares opened at $1.92. The company's stock has experienced significant fluctuations over the past year, with a low of $0.61 and a high reaching $5.77. Quantum-Si has a market capitalization of approximately $274 million, a PE ratio of -3.00, and a beta of 2.69, indicating high volatility. The stock's 50-day simple moving average stands at $2.22, while the 200-day simple moving average is $1.40.

Updates on Analyst Ratings

Recent reports from several brokerages have provided updates on Quantum-Si (QSI). Canaccord Genuity Group has lowered their price target on Quantum-Si shares from $1.50 to $1.00, maintaining a "hold" rating. In contrast, Alliance Global Partners initiated coverage on Quantum-Si with a "buy" rating and a target price of $3.75. Additionally, HC Wainwright confirmed their "buy" rating, setting a price target of $5.50 for the stock.

Insider Trading Activity

In recent insider trading news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si on December 27th at an average price of $3.34, resulting in a total sale of about $11.71 million. Following this sale, Rothberg retains approximately 1,250,000 shares valued at around $4.18 million, reflecting a notable 73.72% decrease in his stake in the company. Details of this transaction are filed with the Securities and Exchange Commission and can be reviewed publicly; company insiders hold around 30.04% of the total stock.

About Quantum-Si

Quantum-Si is a life sciences company focused on the development of a single-molecule detection platform aimed at advancing Next Generation Protein Sequencing (NGPS). The company’s offerings include the Platinum NGPS instrument, Platinum Analysis Software service, along with various reagent kits and semiconductor chips tailored for use with its instruments.

Earnings, Quantum-Si, Stocks